Am. Teppo et al., Changes of urinary alpha 1-microglobulin in the assessment of prognosis inrenal transplant recipients, TRANSPLANT, 70(8), 2000, pp. 1154-1159
Background. After transplantation, even if the graft starts functioning imm
ediately, there are morphological and functional changes in tubular structu
res. In addition, acute allograft rejection causes damage in the tubular ep
ithelium, tubular basement membrane, and intertubular connective tissue. It
also affects the functional capacity of proximal tubular cells resulting i
n impaired reabsorption and thus increased urinary excretion of low molecul
ar weight proteins,
Methods. We present a double-antibody radioimmunoassay for determination of
the concentration of alpha1-microglobulin (alpha1 M) in urine. It was used
to measure urinary excretion of alpha1 RI approximately once a week during
the first 1-6 posttransplant weeks in 136 consecutive patients: 30 patient
s developing acute rejection (75 24-hr urine samples) and 106 patients with
stable graft function (223 24-hr urine samples), The results are expressed
as alpha1 M/creatinine ratios.
Results. Approximately 8 days after transplantation the mean (+/-SD) urinar
y alpha1 M/creatinine ratio of all patients was 17,0+/-14.8 mg/mmol, being
about the same both in patients with uncomplicated posttransplantation cour
se (16.3+/-14.0 mg/mmol) and in those who later developed rejection (19.3+/
-15.1 mg/mmol), but about 60-fold higher than in healthy controls (0.27+/-0
.15 mg/mmol). At that time, when all patients were included there was a cor
relation (r=0,3465, P<0.001) between <alpha>1 M/creatinine ratio and durati
on of cold ischemia, Thereafter, during the second week alpha1 M/creatinine
ratio decreased in 89% of patients with stable graft function, but only in
14% of patients who later developed rejection (P<0.001), On the contrary,
a significant increase (P<0,01) of alpha1 M/creatinine ratio was observed 4
to 1 day before rejection in all 15 patients, who had urines collected at
that time. At the end of the follow-up period, alpha1 M/creatinine ratio in
patients with rejection was 3-fold compared with the nonrejecting patients
, and 100-fold compared with the healthy controls.
Conclusion. These results show that cadaveric transplantation results in im
paired low molecular weight protein reabsorption, the degree of dysfunction
relating to the duration of cold ischemia, and suggest that during the pos
ttransplant weeks decreasing alpha1 M/creatinine ratio in consecutively col
lected urine samples indicates improved tubular function and in most cases
rules out development of acute rejection.